• Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: Long-Acting Injectable Antipsychotics in Practice

Dec 9th, 2021

Treating Schizophrenia

Long-acting injectable (LAI) antipsychotic formulations are being considered more often in the treatment of schizophrenia to promote medication adherence. Genoa Healthcare recently hosted a webinar providing an update on available LAIs and addressing potential reasons for starting patients on the medications. Can Genoa help your clinic and consumers with LAIs?

Click here to review general clinical considerations and pearls regarding the long-acting injectable antipsychotics available.

The webinar also addressed recent COVID-19 developments, including updates on the Omicron variant and new oral antiviral medications.

  • Learn more about the Omicron Variant and frequently asked questions surrounding COVID-19 here.
  • Review Pfizer-BioNTech COVID-19 vaccine product presentations here.

Watch the recording below:

To learn more about how Genoa can help you and those you serve, contact us today.

Recent Posts

Read More
  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...
  • Consumer Stories
  • Partnering with Genoa
  • People-first Pharmacy Care
“It was really emotional”: Genoa pharmacist turned director reunites with consumer

When Jeannie Barrett, PharmD, transitioned from her role as a pharmacist to director of pharmacy operations for Genoa Healthcare, she wondered if she’d get the chance to see her consumers...
  • Clinical Insights
  • Treatment
RELEXXII®: 6 things to know about the new FDA-approved treatment for ADHD

Staying on top of new medication options for your consumers living with ADHD can be difficult. Learn more about the new FDA-approved medication RELEXXII®, a long-acting formulation of methylphenidate. 1....
  • Partnering with Genoa
  • People-first Pharmacy Care
3 reasons to transition your pharmacy to Genoa Healthcare

Having a pharmacy right within your clinic offers a lot of benefits: it can break down barriers to care, improve consumer and provider satisfaction and drive better outcomes for the...